Global Aortic Valve Replacement Devices Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028
Global Aortic Valve Replacement Devices Market Overview:
“The global Aortic Valve Replacement Devices Market size is expected to be worth around US$ xx Billion by 2021 from US$ X.xx million in 2031, growing at a CAGR of X.x% during the forecast period 2021 to 2031.
There are millions of people affected with the aortic valve disease and the treatment for the AVD in most of the cases is prosthetic aortic valve replacement which includes replacement of the native aortic valve with a prosthetic valve. Among the general population, 0.4% are affected with Calcific Aortic Stenosis (CAS), in this case, the formation of fibro-calcic nodules takes place on the valve.
In cases of native aortic valve degeneration medicines are not preferred solution as they are not able to stop the degeneration process. The most feasible solution available is reparation/reconstruction of valves whereas, and in extreme cases replacement is the only available option.
Global Aortic Valve Replacement Devices Market: Dynamics
Rising incidences of aortic valve stenosis across the globe and an increasing number of surgeries related to transcatheter aortic valve replacement are major factors expected to drive growth of the global aortic valve replacement devices market. According to the Journal of Nursing and Health Science, globally more than 30,000 patients undergone treatment by Transcatheter Aortic Valve Replacement.
In addition, well-developed healthcare infrastructure and favorable reimbursement policies in developed countries are among other factors expected to further support growth of the global market.
Moreover, the rising geriatric population across the globe suffering from various heart associated issues, coupled with a growing preference for minimally invasive surgical procedures are some other factors expected to further support growth of the global aortic valve replacement devices market.
However, stringent regulations related to product approval and product recalls due to safety issues are major factors expected to hamper growth of the global aortic valve replacement devices market. In addition, lack of advanced healthcare facilities in order to facilitate open heart surgeries in developing countries and unfavorable regulatory policies are among other factors expected to challenge growth of the global market.
Increasing investment by major players for technological advancements and R&D activities and innovative product offerings is expected to create revenue opportunities for players operating in the target market over the forecast period.
In addition, innovative product offerings by the major player are expected to further support growth of the target market to a certain extent. In 2017, the FDA approved The Edwards SAPIEN 3 Trans catheter Heart Valve – for commercial use in the US, it consists of a catheter-based artificial heart valve and accessories used to implant valve without open-heart surgery
Global Aortic Valve Replacement Devices Market: Region
The market in North American is expected to dominate in the global aortic valve replacement devices market and is expected to continue its dominance over the forecast period. This can be attributed to the availability of well-developed healthcare facilities for R&D activities, favorable reimbursement policies, and the presence of major players operating in the countries in this region.
In addition, growing merger and acquisition activities between regional and international players is another factor expected to support growth of the target market in this region.
The market in Asia Pacific is expected to witness faster growth, owing to increasing government expenditure on development of healthcare facilities, developing regulations related to use of medical devices, and the presence of prominent players operating in emerging economies in this region.
Global Aortic Valve Replacement Devices Market Segmentation
Segmentation by surgery
- Open surgery
- Minimally invasive surgery
Segmentation by product
- Transcatheter aortic valve
- Sutureless valve
Segmentation by end-user
- Ambulatory surgery centers
Segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Boston Scientific Corporation
- Cryolife, Inc.
- Edward Lifesciences Corporation
- LivaNova PLC.
- Medtronic Plc.
- Jude Medical, Inc.
- Symetis SA
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!